This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Principal Results From the Women's Health Initiative Randomized Controlled Trial

Writing Group for the Women's Health Initiative Investigators

JAMA. 2002;288:321-333.

Context  Despite decades of accumulated observational evidence, the balance of risks and benefits for hormone use in healthy postmenopausal women remains uncertain.

Objective  To assess the major health benefits and risks of the most commonly used combined hormone preparation in the United States.

Design  Estrogen plus progestin component of the Women's Health Initiative, a randomized controlled primary prevention trial (planned duration, 8.5 years) in which 16608 postmenopausal women aged 50-79 years with an intact uterus at baseline were recruited by 40 US clinical centers in 1993-1998.

Interventions  Participants received conjugated equine estrogens, 0.625 mg/d, plus medroxyprogesterone acetate, 2.5 mg/d, in 1 tablet (n = 8506) or placebo (n = 8102).

Main Outcomes Measures  The primary outcome was coronary heart disease (CHD) (nonfatal myocardial infarction and CHD death), with invasive breast cancer as the primary adverse outcome. A global index summarizing the balance of risks and benefits included the 2 primary outcomes plus stroke, pulmonary embolism (PE), endometrial cancer, colorectal cancer, hip fracture, and death due to other causes.

Results  On May 31, 2002, after a mean of 5.2 years of follow-up, the data and safety monitoring board recommended stopping the trial of estrogen plus progestin vs placebo because the test statistic for invasive breast cancer exceeded the stopping boundary for this adverse effect and the global index statistic supported risks exceeding benefits. This report includes data on the major clinical outcomes through April 30, 2002. Estimated hazard ratios (HRs) (nominal 95% confidence intervals [CIs]) were as follows: CHD, 1.29 (1.02-1.63) with 286 cases; breast cancer, 1.26 (1.00-1.59) with 290 cases; stroke, 1.41 (1.07-1.85) with 212 cases; PE, 2.13 (1.39-3.25) with 101 cases; colorectal cancer, 0.63 (0.43-0.92) with 112 cases; endometrial cancer, 0.83 (0.47-1.47) with 47 cases; hip fracture, 0.66 (0.45-0.98) with 106 cases; and death due to other causes, 0.92 (0.74-1.14) with 331 cases. Corresponding HRs (nominal 95% CIs) for composite outcomes were 1.22 (1.09-1.36) for total cardiovascular disease (arterial and venous disease), 1.03 (0.90-1.17) for total cancer, 0.76 (0.69-0.85) for combined fractures, 0.98 (0.82-1.18) for total mortality, and 1.15 (1.03-1.28) for the global index. Absolute excess risks per 10 000 person-years attributable to estrogen plus progestin were 7 more CHD events, 8 more strokes, 8 more PEs, and 8 more invasive breast cancers, while absolute risk reductions per 10 000 person-years were 6 fewer colorectal cancers and 5 fewer hip fractures. The absolute excess risk of events included in the global index was 19 per 10 000 person-years.

Conclusions  Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women. All-cause mortality was not affected during the trial. The risk-benefit profile found in this trial is not consistent with the requirements for a viable intervention for primary prevention of chronic diseases, and the results indicate that this regimen should not be initiated or continued for primary prevention of CHD.

Writing Group for the Women's Health Initiative Investigators: Jacques E. Rossouw, MBChB, MD, National Heart, Lung, and Blood Institute, Bethesda, Md; Garnet L. Anderson, PhD, Ross L. Prentice, PhD, Andrea Z. LaCroix, PhD, and Charles Kooperberg, PhD, Fred Hutchinson Cancer Research Center, Seattle, Wash; Marcia L. Stefanick, PhD, Stanford University Clinical Center, Stanford, Calif; Rebecca D. Jackson, MD, Ohio State University Clinical Center, Columbus; Shirley A. A. Beresford, PhD, Fred Hutchinson Cancer Research Center, Seattle, Wash; Barbara V. Howard, PhD, MedStar Research Institute, Washington, DC; Karen C. Johnson, MD, MPH, University of Tennessee, Memphis; Jane Morley Kotchen, MD, Medical College of Wisconsin, Milwaukee; Judith Ockene, PhD, University of Massachusetts Medical School, Worcester.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Menopause, evolution and changing cultures
Shaw and Shaw
Menopause Int 2009;15:175-179.
ABSTRACT | FULL TEXT  

Changes in Postmenopausal Hormone Replacement Therapy Use Among Women With High Cardiovascular Risk
Hsu et al.
AJPH 2009;99:2184-2187.
ABSTRACT | FULL TEXT  

Brain Volumes, Cognitive Impairment, and Conjugated Equine Estrogens
Espeland et al.
J Gerontol A Biol Sci Med Sci 2009;64A:1243-1250.
ABSTRACT | FULL TEXT  

Estrogen replacement restores flow-induced vasodilation in coronary arterioles of aged and ovariectomized rats
LeBlanc et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009;297:R1713-R1723.
ABSTRACT | FULL TEXT  

Mammographic Screening and Risk Factors for Breast Cancer
Cook et al.
Am J Epidemiol 2009;170:1422-1432.
ABSTRACT | FULL TEXT  

Glutathione peroxidase deficiency exacerbates ischemia-reperfusion injury in male but not female myocardium: insights into antioxidant compensatory mechanisms
Lim et al.
Am. J. Physiol. Heart Circ. Physiol. 2009;297:H2144-H2153.
ABSTRACT | FULL TEXT  

Estrogen replacement therapy in diabetic ovariectomized female rats potentiates postischemic leukocyte adhesion in cerebral venules via a RAGE-related process
Xu et al.
Am. J. Physiol. Heart Circ. Physiol. 2009;297:H2059-H2067.
ABSTRACT | FULL TEXT  

Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores
Hippisley-Cox and Coupland
BMJ 2009;339:b4229-b4229.
ABSTRACT | FULL TEXT  

Recent Changes in Breast Cancer Incidence in Spain, 1980-2004
Pollan et al.
JNCI J Natl Cancer Inst 2009;101:1584-1591.
ABSTRACT | FULL TEXT  

Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer
Nelson et al.
ANN INTERN MED 2009;151:703-715.
ABSTRACT | FULL TEXT  

Smoking may be considered an established risk factor for sporadic ALS
Armon
Neurology 2009;73:1693-1698.
ABSTRACT | FULL TEXT  

Genetic Variation in the Progesterone Receptor and Metabolism Pathways and Hormone Therapy in Relation to Breast Cancer Risk
Reding et al.
Am J Epidemiol 2009;170:1241-1249.
ABSTRACT | FULL TEXT  

Estrogen-Progestagen Menopausal Hormone Therapy and Breast Cancer: Does Delay From Menopause Onset to Treatment Initiation Influence Risks?
Fournier et al.
JCO 2009;27:5138-5143.
ABSTRACT | FULL TEXT  

Combined Hormone Therapy at Menopause and Breast Cancer: A Warning--Short-Term Use Increases Risk
Bernstein
JCO 2009;27:5116-5119.
FULL TEXT  

Influence of Age and Obesity on Serum Estradiol, Estrone, and Sex Hormone Binding Globulin Concentrations following Oral Estrogen Administration in Postmenopausal Women
Karim et al.
J. Clin. Endocrinol. Metab. 2009;94:4136-4143.
ABSTRACT | FULL TEXT  

Colorectal Cancer Incidence and Postmenopausal Hormone Use by Type, Recency, and Duration in Cancer Prevention Study II
Hildebrand et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:2835-2841.
ABSTRACT | FULL TEXT  

Effects of Conjugated Equine Estrogens on Cognition and Affect in Postmenopausal Women with Prior Hysterectomy
Resnick et al.
J. Clin. Endocrinol. Metab. 2009;94:4152-4161.
ABSTRACT | FULL TEXT  

Variation in the FGFR2 Gene and the Effects of Postmenopausal Hormone Therapy on Invasive Breast Cancer
Prentice et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:3079-3085.
ABSTRACT | FULL TEXT  

Salivary Sex Hormone Measurement in a National, Population-Based Study of Older Adults
Gavrilova and Lindau
J Gerontol B Psychol Sci Soc Sci 2009;64B:i94-i105.
ABSTRACT | FULL TEXT  

Osteoporosis Disease Management: What Every Orthopaedic Surgeon Should Know
Dell et al.
JBJS 2009;91:79-86.
FULL TEXT  

Low rates of treatment in postmenopausal women with a history of low trauma fractures: results of audit in a Fracture Liaison Service
Premaor et al.
QJM 2009;0:hcp154v1-hcp154.
ABSTRACT | FULL TEXT  

New-Onset Breast Tenderness After Initiation of Estrogen Plus Progestin Therapy and Breast Cancer Risk
Crandall et al.
Arch Intern Med 2009;169:1684-1691.
ABSTRACT | FULL TEXT  

Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis
Huber et al.
Hum Reprod Update 2009;0:dmp040v1-dmp040.
FULL TEXT  

Complementary and Alternative Medications for Women's Health Issues
Lloyd and Hornsby
Nutr Clin Pract 2009;24:589-608.
ABSTRACT | FULL TEXT  

Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes
Arendt et al.
J Endocrinol 2009;203:99-110.
ABSTRACT | FULL TEXT  

Antiresorptive Effects of Phytoestrogen Supplements Compared with Estradiol or Risedronate in Postmenopausal Women Using 41Ca Methodology
Weaver et al.
J. Clin. Endocrinol. Metab. 2009;94:3798-3805.
ABSTRACT | FULL TEXT  

Supplemental Dietary Racemic Equol Has Modest Benefits to Bone but Has Mild Uterotropic Activity in Ovariectomized Rats
Legette et al.
J. Nutr. 2009;139:1908-1913.
ABSTRACT | FULL TEXT  

Should the ovaries be removed or retained at the time of hysterectomy for benign disease?
Hickey et al.
Hum Reprod Update 2009;0:dmp037v1-dmp037.
ABSTRACT | FULL TEXT  

The Relationship Between Cognitive Function and Physical Performance in Older Women: Results From the Women's Health Initiative Memory Study
Atkinson et al.
J Gerontol A Biol Sci Med Sci 2009;0:glp149v1-glp149.
ABSTRACT | FULL TEXT  

"Timing Hypothesis" for Hormone Therapy: Still Viable, or Time to Let Go?
JWatch General 2009;2009:1-1.
FULL TEXT  

Gains in Body Fat and Vasomotor Symptom Reporting Over the Menopausal Transition: The Study of Women's Health Across the Nation
Thurston et al.
Am J Epidemiol 2009;170:766-774.
ABSTRACT | FULL TEXT  

Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer
Nelson et al.
ANN INTERN MED 2009;0:0000605-200911170-00147v1-E-147.
ABSTRACT | FULL TEXT  

Should We Manage Patients With Non-ST Segment Elevation Myocardial Infarction With Renal Failure With an Invasive Strategy?
Cannon
Circulation 2009;120:828-830.
FULL TEXT  

Better regulation of industry-sponsored clinical trials is long overdue.
Wynia and Boren
J Law Med Ethics 2009;37:410-419.
 

Efficacy, Safety, and Tolerability of Low-Dose Hormone Therapy in Managing Menopausal Symptoms
Langer
J Am Board Fam Med 2009;22:563-573.
ABSTRACT | FULL TEXT  

Hormone replacement therapy and the endometrium
Daayana and Holland
Menopause Int 2009;15:134-138.
ABSTRACT | FULL TEXT  

Radiation-induced hypopituitarism
Fernandez et al.
Endocr Relat Cancer 2009;16:733-772.
ABSTRACT | FULL TEXT  

Update on acute pulmonary embolism
Sanchez et al.
ERR 2009;18:137-147.
FULL TEXT  

Development, Implementation, and Assessment of a Lecture Course on Cancer for Undergraduates
Shuster and Peterson
cellbioed 2009;8:193-202.
ABSTRACT | FULL TEXT  

Disruption of estrogen receptor signaling enhances intestinal neoplasia in ApcMin/+ mice
Cleveland et al.
Carcinogenesis 2009;30:1581-1590.
ABSTRACT | FULL TEXT  

Gender Differences in Cardiac Ischemic Injury and Protection--Experimental Aspects
Ostadal et al.
Exp. Biol. Med. 2009;234:1011-1019.
ABSTRACT | FULL TEXT  

Effects of Oral Estrogen on Aortic ROS-Generating and -Scavenging Enzymes and Atherosclerosis in apoE-Deficient Mice
Wing et al.
Exp. Biol. Med. 2009;234:1037-1046.
ABSTRACT | FULL TEXT  

Response to Letters by Furlan, and Kohrmann and Schwab
Grotta and Barreto
Stroke 2009;40:e536-e536.
FULL TEXT  

Steady-State Pharmacokinetics Following Application of a Novel Transdermal Estradiol Spray in Healthy Postmenopausal Women
Morton et al.
J Clin Pharmacol 2009;49:1037-1046.
ABSTRACT | FULL TEXT  

ER{alpha}, ER{beta}, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis
Meyer and Barton
Cardiovasc Res 2009;83:605-610.
FULL TEXT  

Understanding Estrogen Action during Menopause
Iqbal and Zaidi
Endocrinology 2009;150:3443-3445.
FULL TEXT  

Estrogen Receptor-{beta} Activation Results in S-Nitrosylation of Proteins Involved in Cardioprotection
Lin et al.
Circulation 2009;120:245-254.
ABSTRACT | FULL TEXT  

"Staging the Aging" When Considering Androgen Deprivation Therapy for Older Men With Prostate Cancer
Dale
JCO 2009;27:3420-3422.
FULL TEXT  

Comparative effectiveness research: Relevance and applications to pharmacy
Schumock and Pickard
Am J Health Syst Pharm 2009;66:1278-1286.
ABSTRACT | FULL TEXT  

Menopause and Ovariectomy Cause a Low Grade of Systemic Inflammation that May Be Prevented by Chronic Treatment with Low Doses of Estrogen or Losartan
Abu-Taha et al.
J. Immunol. 2009;183:1393-1402.
ABSTRACT | FULL TEXT  

Progesterone Inhibits Activation-Induced Deaminase by Binding to the Promoter
Pauklin and Petersen-Mahrt
J. Immunol. 2009;183:1238-1244.
ABSTRACT | FULL TEXT  

Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends
Jorgensen and Gotzsche
BMJ 2009;339:b2587-b2587.
ABSTRACT | FULL TEXT  

Relationship between Migraine History and Breast Cancer Risk among Premenopausal and Postmenopausal Women
Li et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:2030-2034.
ABSTRACT | FULL TEXT  

Trends and determinants of prescription medication use for treatment of osteoporosis
Farley and Blalock
Am J Health Syst Pharm 2009;66:1191-1201.
ABSTRACT | FULL TEXT  

Finally! A Model for Progesterone Receptor Action in Normal Human Breast
Lydon and Edwards
Endocrinology 2009;150:2988-2990.
FULL TEXT  

Bone Mineral Density in Estrogen-Deficient Young Women
Popat et al.
J. Clin. Endocrinol. Metab. 2009;94:2277-2283.
ABSTRACT | FULL TEXT  

Ovariectomy and 17{beta}-Estradiol Replacement Do Not Alter {beta}-Amyloid Levels in Sheep Brain
Barron et al.
Endocrinology 2009;150:3228-3236.
ABSTRACT | FULL TEXT  

Endometrium protection and acceptability of nasally administered continuously combined hormone therapy: a multicentre, multinational, double-blind trial in post-menopausal women evaluating three regimens of 17{beta}-estradiol and norethisterone when compared with an orally administered 17{beta}-estradiol norethisterone regimen
Rozenberg et al.
Hum Reprod 2009;24:1739-1747.
ABSTRACT | FULL TEXT  

Invited Commentary: Hormone Therapy Risks and Benefits--The Women's Health Initiative Findings and the Postmenopausal Estrogen Timing Hypothesis
Banks and Canfell
Am J Epidemiol 2009;170:24-28.
ABSTRACT | FULL TEXT  

Benefits and Risks of Postmenopausal Hormone Therapy When It Is Initiated Soon After Menopause
Prentice et al.
Am J Epidemiol 2009;170:12-23.
ABSTRACT | FULL TEXT  

Cancer Prevention: From 1727 to Milestones of the Past 100 Years
Lippman and Hawk
Cancer Res. 2009;69:5269-5284.
ABSTRACT | FULL TEXT  

Postmenopausal Hypertension: Mechanisms and Therapy
Barton and Meyer
Hypertension 2009;54:11-18.
FULL TEXT  

Postmenopausal Hormone Treatment
Hulley and Grady
JAMA 2009;301:2493-2495.
FULL TEXT  

Newer Antidepressants and Gabapentin for Hot Flashes: An Individual Patient Pooled Analysis
Loprinzi et al.
JCO 2009;27:2831-2837.
ABSTRACT | FULL TEXT  

The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer
Lanari et al.
Endocr Relat Cancer 2009;16:333-350.
ABSTRACT | FULL TEXT  

Success with Men's Educational Group Appointments (MEGA): Subjective Improvements in Patient Education
Campbell et al.
Am J Mens Health 2009;3:173-178.
ABSTRACT  

Vascular Effects of Estrogen and Progestins and Risk of Coronary Artery Disease: Importance of Timing of Estrogen Treatment
Gungor et al.
ANGIOLOGY 2009;60:308-317.
ABSTRACT  

Low-fat, increased fruit, vegetable, and grain dietary pattern, fractures, and bone mineral density: the Women's Health Initiative Dietary Modification Trial
McTiernan et al.
Am. J. Clin. Nutr. 2009;89:1864-1876.
ABSTRACT | FULL TEXT  

Why should clinicians understand epidemiology?
McAllister and Wild
Postgrad. Med. J. 2009;85:313-315.
ABSTRACT | FULL TEXT  

Herb-related aneuploidy in breast fibroadenoma
Chang et al.
BMJ Case Reports 2009;2009:bcr0920080926-bcr0920080926.
ABSTRACT | FULL TEXT  

Colorectal Cancer in Relation to Postmenopausal Estrogen and Estrogen Plus Progestin in the Women's Health Initiative Clinical Trial and Observational Study
Prentice et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:1531-1537.
ABSTRACT | FULL TEXT  

Diffusion of Breast Cancer Risk Assessment in Primary Care
Guerra et al.
J Am Board Fam Med 2009;22:272-279.
ABSTRACT | FULL TEXT  

The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute?
Howick et al.
JRSM 2009;102:186-194.
FULL TEXT  

Searching for a Safe Analgesic in Patients With Cardiovascular Disease
Solomon
Circ Cardiovasc Qual Outcomes 2009;2:146-147.
FULL TEXT  

Breast cancer in young women and its impact on reproductive function
Hickey et al.
Hum Reprod Update 2009;15:323-339.
ABSTRACT | FULL TEXT  

Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone
Fanciulli et al.
Hum Reprod Update 2009;15:341-358.
ABSTRACT | FULL TEXT  

Perspectives on the soy-breast cancer relation
Messina and Wu
Am. J. Clin. Nutr. 2009;89:1673S-1679S.
ABSTRACT | FULL TEXT  

Changes in Estrogen Receptor, Progesterone Receptor and Her-2/neu Status with Time: Discordance Rates Between Primary and Metastatic Breast Cancer
BROOM et al.
Anticancer Res 2009;29:1557-1562.
ABSTRACT | FULL TEXT  

Short-term Prophylactic Tamoxifen Reduces the Incidence of Antiestrogen-Resistant/Estrogen Receptor-Positive/Progesterone Receptor-Negative Mammary Tumors
Rose-Hellekant et al.
Cancer Prevention Research 2009;2:496-502.
ABSTRACT | FULL TEXT  

Baroreflex sensitivity varies during the rat estrous cycle: role of gonadal steroids
Goldman et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009;296:R1419-R1426.
ABSTRACT | FULL TEXT  

Orally Administered Lactoferrin Preserves Bone Mass and Microarchitecture in Ovariectomized Rats
Guo et al.
J. Nutr. 2009;139:958-964.
ABSTRACT | FULL TEXT  

Cardiovascular Effects of Physiological and Standard Sex Steroid Replacement Regimens in Premature Ovarian Failure
Langrish et al.
Hypertension 2009;53:805-811.
ABSTRACT | FULL TEXT  

When to Start Antiretroviral Therapy -- Ready When You Are?
Sax and Baden
NEJM 2009;360:1897-1899.
FULL TEXT  

Drospirenone in HRT?
DTB 2009;47:41-44.
ABSTRACT | FULL TEXT  

Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease
Hochman et al.
Lupus 2009;18:313-317.
ABSTRACT  

Are Statin Effects Mediated Through, or in Spite of, Their Cholesterol-lowering Action?
Mascitelli et al.
ANGIOLOGY 2009;60:262-263.
 

Childhood Soy Intake and Breast Cancer Risk in Asian American Women
Korde et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:1050-1059.
ABSTRACT | FULL TEXT  

Certain Progestins Prevent the Enhancing Effect of 17{beta}-Estradiol on NO-Mediated Inhibition of Platelet Aggregation by Endothelial Cells
Zerr-Fouineau et al.
Arterioscler. Thromb. Vasc. Bio. 2009;29:586-593.
ABSTRACT | FULL TEXT  

Interference of Progestins With Endothelial Actions of Estrogens: A Matter of Glucocorticoid Action or Deprivation?
Arnal et al.
Arterioscler. Thromb. Vasc. Bio. 2009;29:441-443.
FULL TEXT